Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Deutsches Arzteblatt International|July 2, 2009
Important aspects of organ-preserving surgery for renal tumors: indications, new standards, and oncological outcomesFrank Becker, Stefan Siemer, Jörn Kamradt, et al.European Urology|June 30, 2009
Medical therapy to facilitate the passage of stones: what is the evidence?Christian Seitz, Evangelos Liatsikos, Francesco Porpiglia, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2006
Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinomaJan Lehmann, Margitta Retz, Stefan Siemer, et al.The Journal of Urology|February 10, 2004
Lymph node positive prostate cancer: long-term survival data after radical prostatectomyUlrike Zwergel, Jan Lehmann, Bernd Wullich, et al.European Urology|April 10, 2007
Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomyUlrike Zwergel, Henrik Suttmann, Thomas Schroeder, et al.European Urology|November 28, 2006
Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survivalJan Lehmann, Henrik Suttmann, Iva Kovac, et al.BMC Urology|March 5, 2008
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cellsHenrik Suttmann, Margitta Retz, Friedrich Paulsen, et al.Cancer Biotherapy & Radiopharmaceuticals|November 13, 2008
Combining 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experienceHenrik Suttmann, Aleksandar Grgic, Jan Lehmann, et al.Pageof 1